L-Carnitine

L-Carnitine is a naturally occurring quaternary ammonium compound biosynthesized from the amino acids lysine and methionine. It is essential for the transport of long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation, a process known as the carnitine shuttle. L-Carnitine is synthesized endogenously in the liver and kidneys, and is also obtained through dietary intake, particularly from red meat and dairy products. The body maintains a total carnitine pool of approximately 20-25 grams, with over 95% stored in skeletal and cardiac muscle. L-Carnitine exists in two stereoisomers — only the L-form is biologically active. It has been studied extensively in the context of energy metabolism, exercise physiology, and cardiac biology. L-Carnitine is an FDA-approved prescription medication (as levocarnitine) for primary carnitine deficiency and has been investigated in numerous clinical trials across metabolic and cardiovascular research areas.

L-Carnitine has been investigated for its essential role in the mitochondrial carnitine shuttle system. Long-chain fatty acyl-CoA esters cannot cross the inner mitochondrial membrane directly. Carnitine palmitoyltransferase I (CPT-I) on the outer mitochondrial membrane converts fatty acyl-CoA to fatty acyl-carnitine, which is then transported across the inner membrane by carnitine-acylcarnitine translocase (CACT). CPT-II on the inner membrane regenerates fatty acyl-CoA for beta-oxidation, releasing free carnitine to recycle through the shuttle. Researchers observed that L-carnitine also functions as a buffer for the acyl-CoA/CoA ratio, accepting excess acyl groups to maintain free CoA availability for other metabolic pathways. In clinical studies, L-carnitine supplementation has been investigated for its effects on fatty acid oxidation rates, exercise capacity, and recovery markers. The compound also participates in peroxisomal fatty acid oxidation and branched-chain amino acid metabolism.

Carnitine Shuttle Biochemistry

Bremer J (1983) characterized the carnitine palmitoyltransferase system and the role of carnitine in mitochondrial fatty acid transport, establishing the biochemical framework for L-carnitine’s metabolic function [1].

Exercise Physiology

Wall et al. (2011) investigated L-carnitine supplementation in human subjects and observed increased muscle carnitine content and changes in fuel utilization during exercise, demonstrating that chronic supplementation can alter the muscle carnitine pool [2].

Clinical Applications

Flanagan et al. (2010) reviewed L-carnitine’s role in primary and secondary carnitine deficiency, establishing the clinical rationale for supplementation in conditions where endogenous synthesis or dietary intake is insufficient [3].